| Application no. and date | 12756417.7 (espacenet) (Federated) (European Patent Register), 20120827 | | Patent/reg. no. and date | DK/EP 2750699, 20150722 | | Publication date | 20140709 | | Priority no. and date | EP 11179149, 20110829 | | EP pub. no. and date |
EP 2750699 20140709 | | Effective date | | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50
65929 Frankfurt am Main, DE | | Applicant ref. no. | Sanofi DE2011/183-EP-EPT | | Inventor | NIEMÖLLER, Elisabeth, c/o Sanofi-Aventis Deutschland GmbH
Industriepark Höchst
65926 Frankfurt am Main, DE,
MÜHLEN-BARTMER, Isabel, c/o Sanofi-Aventis Deutschland GmbH
Industriepark Höchst
65926 Frankfurt am Main, DE,
SILVESTRE, Louise, c/o Sanofi-Aventis
Département Brevets
54 rue La Boétie
F-75008 Paris, FR,
BOKA, Gabor, c/o Sanofi-Aventis
Département Brevets
54 rue La Boétie
F-75008 Paris, FR,
MIOSSEC, Patrick, c/o Sanofi-Aventis
Département Brevets
54 rue La Boétie
F-75008 Paris, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/155 (2006.01) , A61K 31/4439 (2006.01) , A61K 38/26 (2006.01) | | Title | FARMACEUTISK KOMBINATION TIL ANVENDELSE TIL GLYKÆMISK KONTROL HOS DIABETES-TYPE 2-PATIENTER | | Int. application no. | EP2012066617 | | Int. publication no. | WO2013030160 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
